NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/23/2022
Back to search
Official data from USPTO
PICOBIOTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PICOBIOTICS
ST13
US500000088285675Class
5, 42, 44
Filing
88285675
Registration
6823397
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
08/23/2022
Trademark type
Word
Nice classes
5, 42, 44
Filing date
02/01/2019
Registration date
08/23/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/23/2022
Last transaction
08/23/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Copenhagen, DK
Examiner
STIGLITZ, SUSAN
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
S. A. (pessoa física)
Representatives
Mark H. Tidman Baker & Hostetler LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsantibacterial treatmentsmicrobiome modulating treatmentsanti-infective treatments and prophylaxis; medical preparationsantibacterial treatmentsmicrobiome modulating treatmentsanti-infective treatments and prophylaxismedical diagnostics; veterinary preparationsantibacterial treatmentsmicrobiome modulating treatmentsanti-infective treatments and prophylaxismedical diagnostics; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; antibiotic preparations; pharmaceutical preparationsantiviral preparations; probiotic supplements; probiotic supplements for medical use; probiotic formulations for veterinary useantibacterial treatmentsmicrobiome modulating treatmentsanti-infective treatments and prophylaxis; probiotic formulations for medical useoral formulationsformulations for delivery to a microbiome in a human or animalformulations for delivery to skinhairmouthgutblood or a tissuefluid or organ of a human or animal; microbiome modulators for veterinary purposesanimal feed additives for use in animals feed to assist in digestiongrowth or wellbeing; microbiome modulators for medical purposesas modulators of activity of pharmaceuticals in humans and animals; guided nuclease-based biocides; CRISPR-based biocides; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria
Class 42
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological servicesscientific researchanalysis and testing in the field of diseases and conditions associated with bacteria; industrial analysis and industrial research services; design and development of computer hardware and software; genetic microbiology and microbiome research; genetic engineering and services; design and development of hardware and software; clinical research in the field of microbes and anti-microbial medications; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibiotics; research and development of guided nuclease-based biocides; research and development of CRISPR-based biocides; research and development of CRISPR technology for the treatment of microbial diseases; medical and scientific researchconducting clinical trials for others; clinical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; bacteriological research; medical and scientific research in the field of microbes and anti-microbial medications; biological research; scientific and medical screening and assaying; chemical analysis; chemical research; Medical and health services relating to DNAgenetics and genetic pathogen testingproviding medical and scientific research information in the fields of pharmaceuticals and medicine
Class 44
Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons in the nature of diagnostic and treatment counseling regarding the treatment of medical conditions and disease; pharmaceutical advice; medical and health services relating to DNAgenetics and genetic pathogen testinggenetic testing for medical purposes; genetic counseling
Publications
History of USPTO decisions and trademark events.
42 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/23/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/07/2022
PUBO
PUBLISHED FOR OPPOSITION
06/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/18/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
04/29/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
03/30/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/15/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/15/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/15/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/15/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/15/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/10/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/09/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/10/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/10/2021
CNSI
SUSPENSION INQUIRY WRITTEN
09/10/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/18/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/23/2020
GNSL
LETTER OF SUSPENSION E-MAILED
11/23/2020
CNSL
SUSPENSION LETTER WRITTEN
11/23/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/10/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/26/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/27/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/27/2020
CNSI
SUSPENSION INQUIRY WRITTEN
04/27/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/22/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/15/2019
GNSL
LETTER OF SUSPENSION E-MAILED
10/15/2019
CNSL
SUSPENSION LETTER WRITTEN
10/15/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/08/2019
ALIE
ASSIGNED TO LIE
10/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/02/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/16/2019
GNRT
NON-FINAL ACTION E-MAILED
04/16/2019
CNRT
NON-FINAL ACTION WRITTEN
04/16/2019
DOCK
ASSIGNED TO EXAMINER
04/15/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2019
NWAP
NEW APPLICATION ENTERED
02/05/2019
Continuous trademark protection
Get notified about every new filing that threatens PICOBIOTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.